(17) pharmacology of the git.ppt

Upload: marviecute22

Post on 14-Apr-2018

213 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    1/31

    1

    Pharmacology of the GIT

    The mouth

    a proper flow of saliva is necessary to keep the mouthfresh & free from infection.

    Salivary flow will be diminished in fever, dehydration ,&

    by certain drugs.

    Several oral infection may supervene if salivary flow ismarkedly decreased.

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    2/31

    2

    Prevention of oral infection

    1. Avoid oral infection during surgery

    2. Avoid dehydration

    3. Use mouthwashes

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    3/31

    3

    The major components of mouthrinses:

    1. Water: the major vehicle to solubilize theingredients.

    2. Flavoring: is designed to make mouthrinsepleasant to use.

    3. Humectant: to prevent crystallization around

    the opening of the container.

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    4/31

    4

    4.Surfactant: to solubilize the flavoring agent &provide foaming action.

    5. Alcohol is also helps solubilize some of theingredients present in the formulation.

    6. Active ingredients vary within the productcategory antimicrobial agents, fluoride,astringent salts & chlorophyllins

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    5/31

    5

    Chlorophyllins can serve as topicaldeodorizers to mask halitosis.

    Fluoride rinses will reduce cariouslesions.

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    6/31

    6

    chlorhexidine broad spectrumantibacterialagent

    Depending on the dose, it can interfere withbacterial cell wall transport or disrupt thecell wall.

    Is used in 0.2% solution , the mouth is rinsed2 to 3 times daily with about 10 ml for 1minute.

    The tongue & teeth may be stained brown butthis can be avoided by brushing the teethbefore use.

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    7/31

    7

    General dosing information: The usual adult dose is 10-20 ml. the duration

    of rinsing varies depending on the type of

    agent used.

    The maximal dose for each patient must beindividualized depending on factors as age,

    physical status, ability to effectively rinse &expectorate, oral health & sensitivity.

    Mouthwashes are often not prescribed for

    young pediatrics.

    Reduced maximum doses may be indicated forgeriatric patients

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    8/31

    8

    Patient advise

    The effectiveness of any mouhrinse is tied tothe use of the agent as prescribed by thedentist.

    To receive the greatest antiplaque oranticaries benefit, the patient should rinsebefore retiring to bed

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    9/31

    9

    After using the mouthwash , the patientshould not rinse with water or drink anythingfor at least 30 minutes, immediately drinking

    or rinsing with water will increase the drugclearance from the mouth & reduce itseffectiveness.

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    10/31

    10

    Peptic Ulcer Disease

    Definition

    Break & discontinuity of the mucosa of thestomach or duodenum, penetrating into muscularismucosa

    Factors

    1. Infection with Helicobacter Pylori (H.Pylori)

    2. Increased HCL secretion

    3. Inadequate mucosal defense against gastricacid

    4. Other factors: smoking, NSAIDs, alcohol

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    11/31

    11

    Treatment:

    Aim1. Symptomatic relief

    2. Prevent relapse

    3. Prevent complication

    Non pharmacological approaches

    1. Stop smoking

    2. Avoid alcohol3. Stop the use of ulcerogenic drugs (NSAIDs)

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    12/31

    12

    Pharmacological

    1. Eradicate H.Pylori

    2. Reduce or neutralize the acid3. Protect the gastric mucosa from damage

    Eradication of InfectionH.Pylori adapted to live in the mucus that overlies

    gastric epithelial cells & mucosa in the duodenum

    Gram -ve bacteria that produces enzymes whichcause tissue damage

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    13/31

    13

    H. pylori

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    14/31

    14

    Optimal therapy of patient with peptic ulcer(duodenal & gastric ulcers) who are infected with

    H.Pylori requires antimicrobial treatment

    Various drug combination which are effective:

    Omeprazole (antisecretory)

    Antibiotic like Clarithromycin, Amoxicillin, Tetracycline& Metronidazole

    Triple therapy

    RegimenOmeprazole or Lanzoprazole + Amoxicillin +

    Clarithromycin.

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    15/31

    15

    Eradication of H.Pylori results in rapid healing of active pepticulcer & low recurrence rates (less than 15% compared to 60 to100% per year for patients used traditional antisecretory

    agents)

    2. Reduction of Acidity

    This can be done by inhibit H+ secretion or

    neutralize H+ Gastric acid secretion by parietal cells of the

    gastric mucosa is controlled by:

    1. Acetylcholine2. Histamine they stimulate H+

    3.Gastrin

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    16/31

    16

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    17/31

    17

    4. Prostaglandins (PGs) E2 & I2 inhibit acid secretion,stimulate mucus & bicarbonate secretion.

    A. Drugs Used to Inhibit H+ Secretion

    1.Histamine antagonists (H2-receptorantagonists)

    MOA: blocks histamine receptors

    inhibit H+secretion

    Examples: Cimetidine, Ranitidine

    Indications:

    1. Peptic ulcer

    2. Gastroesophageal reflux disease

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    18/31

    18

    Unwanted effects are rare.

    Cimetidine sometimes gynaecomastia in men &

    rarely, a decrease in sexual function.

    Cimetidine also inhibits cytochrome P450 and

    retard metabolism of a range of drugs.

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    19/31

    19

    2.Proton Pump Inhibitors (PPIs)

    MOA: bind to H+/K+ -ATPase enzyme system,

    suppressing secretion of H+ ions into gastriclumen

    Examples: Omeprazole, Lanzoprazole

    Indications:

    1.As one component of therapy for eradication ofH.Pylori.

    2.Treatment of NSAIDs induced ulcer.

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    20/31

    20

    3. Anti-muscarinic Drugs

    Specific muscarinic M1-receptor antagonists:

    Pirenzepine

    Antacids

    They are weak bases, they reduce gastric acidity byneutralization

    Commonly used antacids are salts of Aluminum &Magnesium as Al(OH)3, Mg(OH)2 either alone or incombination; NaHCO3, CaCO3 also used

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    21/31

    21

    Therapeutic uses:

    For symptomatic relief of peptic ulcer disease & GRED

    S/Es:

    1. Mg-containing antacids cause diarrhea

    2. Al-containing antacids cause constipation

    3.NaHCO3 librates CO2 causing belching & flatulence.

    Should not be given to patients who are on a sodium-

    restricted diet.

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    22/31

    22

    B. Mucosal Protective Agents1.Sucralfate

    It is combination of Al salts & sulfated sucrose

    MOA:In acidic medium, it forms complex gel with mucus, so

    creates a physical barrier that impairs diffusion ofHCLSucralfate should not be administered with antacids,

    H2-antagonists or PPIs

    S/Es: Constipation

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    23/31

    23

    2.Misoprostol

    MOA

    Stable analogue of PGE1, it inhibit gastric acid secretion

    It is used to prevent gastric damage that canoccur with chronic use of NSAIDs

    S/Es: Diarrhea,Uterine contraction may occur

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    24/31

    24

    emetic Agents-Anti

    Nausea & vomiting may occur in variety of

    conditions, for examples:

    1. Motion sickness

    2. Hepatitis

    3. Chemotherapeutic agents4. Pregnancy

    Uncontrolled vomiting can produce dehydration,metabolic imbalance & nutrients depletion

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    25/31

    25

    Receptors mediate emesis:

    1. Histamine receptors [H1]2. Dopamine receptors [D2]

    3. 5-HT3 (serotonin) receptors

    4. Muscarinic receptors

    Anti-emetic classified as antihistamine,anticholinergic, anti-dopaminergic, anti-5-HT3drugs

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    26/31

    26

    exampleDrug class

    MetoclopramideD2-receptor antagonists

    CyclizineHistamine [H1] Receptor

    AntagonistsOndansetron5-HT3 Receptor Antagonists

    HyoscineAntimuscarinic Agents

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    27/31

    27

    Antidiarrheal Agents

    Diarrhea: frequent passage of liquid feces

    Pathophysiology of diarrhea1. motility of GIT

    2. secretion of fluid into GIT lumen

    3. fluid absorption in the intestine

    Causes of diarrhea

    1. Infections

    2.Toxins

    3.Drugs

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    28/31

    28

    Treatment

    1.Maintenance of fluid & electrolyte balanceOral rehydration is the 1st priority

    2. Use of Anti-infective agents

    3. Use of Non-antimicrobial Antidiarrheal agents(Antimotility)

    a. Antimuscarinic agents

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    29/31

    29

    b. Opiates1. Codeine

    2. Loperamide

    S/Es of antimotility agents: constipation.

  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    30/31

    30

    Purgatives (laxatives)

    Constipation: refers to bowel movements

    that are infrequent and/or hard to pass Causes:

    1. Pregnancy2. Drugs3. Elderly patients4. Diet contents

    Treatment:1. Remove the cause2. Accelerate the movement of food through

    GIT by several methods:

    i di dl tiTh ti f

    http://en.wikipedia.org/wiki/Bowel_movementhttp://en.wikipedia.org/wiki/Bowel_movement
  • 7/30/2019 (17) Pharmacology of the GIT.ppt

    31/31

    31

    is discouraged,laxativesThe routine use ofas having bowel movements may come to be

    dependent upon their use.

    Examples

    Classes

    MethylcelluloseBulk laxatives

    LactuloseOsmotic laxatives

    GlycerinsuppositoriesFecal softener

    BisacodylStimulantPurgatives